U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07036458) titled 'To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects' on June 16.
Brief Summary: To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male Subjects
Study Start Date: July 24
Study Type: INTERVENTIONAL
Condition:
Healthy Male Adults
Intervention:
DRUG: 14C Epaminurad Oral Solution
Subjects will receive a single administration of 14C Epaminurad Oral Solution
Recruitment Status: NOT_YET_RECRUITING
Sponsor: JW Pharmaceutical
Disclaimer: Curated by HT Syndication....